MedTrace Logo

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06727669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-12-11

No results posted yet for this study

Summary

This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic information, diagnostic and treatment information, as well as medical expense information of patients from medical records.The incidence and risk factors of thrombosis and hemostasis diseases, the treatment methods, prognosis and medical expenses of these patients in China will be analyzed. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.

Conditions

  • Immune Thrombocytopenia
  • Thrombotic Thrombocytopenic Purpura
  • Hemophilia A, Acquired
  • Disseminated Intravascular Coagulation
  • Thrombophilia
  • Deep Vein Thrombosis
  • Pulmonary Embolism
  • Thrombotic Microangiopathies
  • Coagulation Factor Deficiency
  • Hemophilia A
  • Hemophilia B
  • Hemophilia B, Acquired
  • Platelet Dysfunction
  • Arterial Thromboembolism
  • Bleeding Disorder
  • Thrombosis

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Xiao-Hui Zhang, MD · Peking University Institute of Hematology, Peking University People's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727669 on ClinicalTrials.gov